SNOA - Sonoma Pharmaceuticals, Inc.
2.38
-0.226 -9.496%
Share volume: 33,735
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$2.61
-0.23
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 01-07-2025 | 08-08-2024 | 11-07-2024 | 02-05-2025 | 06-17-2025 | 08-07-2025 | 11-04-2025 | 02-10-2026 | |
| Assets | |||||||||
| Total Assets | 14.740 M | 13.673 M | 13.685 M | 13.668 M | 13.693 M | 14.594 M | 13.856 M | 13.623 M | |
| Current Assets | 12.548 M | 11.927 M | 12.221 M | 12.380 M | 12.648 M | 13.107 M | 12.501 M | 12.145 M | |
| Inventories | 2.719 M | 2.658 M | 2.837 M | 3.143 M | 2.915 M | 3.802 M | 3.634 M | 3.703 M | |
| Other Current Assets | 262.000 K | 237.000 K | 220.000 K | 209.000 K | 212.000 K | 230.000 K | 204.000 K | 148.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.128 M | 2.589 M | 4.078 M | 5.236 M | 5.374 M | 3.605 M | 3.035 M | 2.561 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 365.000 K | 302.000 K | 255.000 K | 215.000 K | 225.000 K | 301.000 K | 284.000 K | 314.000 K | |
| Other Assets | 1.827 M | 1.444 M | 1.209 M | 1.073 M | 820.000 K | 1.186 M | 1.071 M | 1.164 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 14.740 M | 13.673 M | 13.685 M | 13.668 M | 13.693 M | 14.594 M | 13.856 M | 13.623 M | |
| Total liabilities | 8.603 M | 8.698 M | 8.333 M | 8.798 M | 9.282 M | 10.538 M | 10.069 M | 10.191 M | |
| Total current liabilities | 3.719 M | 3.751 M | 3.309 M | 3.703 M | 4.096 M | 4.848 M | 4.322 M | 4.217 M | |
| Accounts Payable | 2.720 M | 2.979 M | 2.792 M | 3.311 M | 3.177 M | 3.882 M | 3.428 M | 3.757 M | |
| Other liabilities | 4.797 M | 4.883 M | 4.979 M | 5.065 M | 5.169 M | 5.686 M | 5.747 M | 5.974 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 4.797 M | 4.883 M | 4.979 M | 5.065 M | 5.169 M | 5.686 M | 5.747 M | 5.974 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.137 M | 4.975 M | 5.352 M | 4.870 M | 4.411 M | 4.056 M | 3.787 M | 3.432 M | |
| Common stock | 203.209 M | 204.071 M | 205.651 M | 206.454 M | 206.593 M | 206.673 M | 206.733 M | 207.023 M | |
| Retained earnings | -194.349 M | -195.492 M | -196.102 M | -197.030 M | -197.806 M | -199.047 M | -199.581 M | -200.400 M |